TCL科技今日耗資1.5億元回購股份
6月25日,TCL科技(000100.SZ)發佈公吿稱,首次通過回購專用證券賬户以集中競價交易方式回購公司股份,回購股份數量為19,281,200股,佔公司總股本的0.14%。本次回購股份最高成交價為7.80元/股,最低成交價為7.69元/股。公司表示,實施回購是基於對科技產業長期發展和企業價值持續成長的信心,亦是為維護廣大投資者利益、兼顧公司員工激勵的需求。
早在6月20日,TCL科技審議通過《關於2021年回購部分社會公眾股份的議案》,今年將回購股份的總金額不低於6億元且不超過7億元。TCL科技目前已支付的回購總金額約1.5億元,意味着還有不低於4.5億元的“子彈”可打。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.